Salarius corrects S&P CapIQ error about Nasdaq delisting after merger Nov 19, 2025 02:44PM
Salarius Pharmaceuticals Cites Errors on S&P CapIQ Platform Following Merger with Decoy Therapeutics, Affirms Its Shares Continue to Trade on the Nasdaq Stock Market Under the Symbol “SLRX” Nov 19, 2025 02:42PM
Pre-Open Stock Movers 08/25: (LWAC) (DKS) (BLFS) Higher; (SAVA) (JWN) (LMNR) Lower (more...) Aug 25, 2021 09:28AM